Evidence map›Paper›PMID 41426817›Full record

ArticleCureus2025

Epidemiology and Antifungal Susceptibility of Candida Bloodstream Isolates From a Tertiary Care Center in Central India.

Arati A Bhadade, Gajendra Singh, Tadepalli Karuna, Madhu Panthi, Ankita Beniwal, Anand K Maurya, Neha Upadhyay, V R Reddy, Apoorva Devgade, Sagar Khadanga

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Arati A BhadadeMicrobiology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Gajendra SinghMicrobiology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Tadepalli KarunaMicrobiology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Madhu PanthiMicrobiology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Ankita BeniwalMicrobiology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Anand K MauryaMicrobiology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Neha UpadhyayMicrobiology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
V R ReddyMicrobiology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Apoorva DevgadeMicrobiology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Sagar KhadangaGeneral Medicine, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFungal bloodstream infections (BSIs), particularly candidemia, are recognized as major contributors to hospital-acquired infections and mortality. Early species and antifungal drug resistance pattern identification are crucial for timely intervention and improved outcomes. Consequently, this study aimed to examine the distribution of

methodsThis retrospective observational study was conducted between January and December 2024.

resultsCandidemia was detected in 118 (0.73%) of total blood culture samples (

conclusionsThe increasing prevalence of non-albicans Candida (NAC) species and the rising resistance to commonly used antifungals, particularly azoles, underscore the importance of timely diagnosis, species-level identification, antifungal drug resistance testing, and targeted antifungal therapy for candidemia. Higher antifungal drug resistance to posaconazole and fluconazole across several Candida isolates highlights the importance of routine antifungal drug resistance testing for Candida isolates in BSIs. Echinocandins are generally effective against most

Indexed as

antifungal resistanceantifungal susceptibility testingbloodstream infection (bsi)candida speciesnon-albicans candida

Identifiers

PMID41426817
PMCPMC12712411

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.